These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7866277

  • 1. Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
    Colgan JP, Andersen J, Habermann TM, Earle JD, O'Connell MJ, Neiman RS, Mann RB, Glick JH.
    Leuk Lymphoma; 1994 Oct; 15(3-4):291-6. PubMed ID: 7866277
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
    Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S.
    Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659
    [Abstract] [Full Text] [Related]

  • 3. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR.
    Blood; 1995 Apr 15; 85(8):2025-37. PubMed ID: 7718875
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 5. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Miller TP.
    N Engl J Med; 1993 Apr 08; 328(14):1002-6. PubMed ID: 7680764
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P, Wood L.
    Eur J Haematol; 1992 Aug 08; 49(2):53-8. PubMed ID: 1397240
    [Abstract] [Full Text] [Related]

  • 7. Aggressive treatment improves survival in adult acute lymphoblastic leukemia.
    Smedmyr B, Killander A, Simonsson B, Sundström C.
    Eur J Haematol; 1988 Nov 08; 41(5):478-81. PubMed ID: 3208869
    [Abstract] [Full Text] [Related]

  • 8. Treatment of adult acute lymphoblastic leukaemia.
    Jacobs P, Wood L, Novitzky N.
    Haematol Blood Transfus; 1990 Nov 08; 33():428-31. PubMed ID: 2323650
    [Abstract] [Full Text] [Related]

  • 9. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct 08; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 10. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ, Hu LY, Geng QR, Chen J, Lu ZH, Rao HL, Liu Q, Jiang WQ, Huang HQ, Lin TY, Xia ZJ.
    Chin J Cancer; 2016 Sep 13; 35(1):87. PubMed ID: 27624700
    [Abstract] [Full Text] [Related]

  • 11. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA.
    Cancer; 1995 May 15; 75(10):2623-31. PubMed ID: 7736409
    [Abstract] [Full Text] [Related]

  • 12. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
    Tubergen DG, Krailo MD, Meadows AT, Rosenstock J, Kadin M, Morse M, King D, Steinherz PG, Kersey JH.
    J Clin Oncol; 1995 Jun 15; 13(6):1368-76. PubMed ID: 7751881
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
    Cancer; 2004 Dec 15; 101(12):2788-801. PubMed ID: 15481055
    [Abstract] [Full Text] [Related]

  • 14. The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.
    O'Neill BP, Wang CH, O'Fallon JR, Colgan JP, Earle JD, Krigel RL, Brown LD, McGinnis WJ.
    Neuro Oncol; 1999 Jul 15; 1(3):196-203. PubMed ID: 11554388
    [Abstract] [Full Text] [Related]

  • 15. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 15; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 16. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
    Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, Bottelli C, Conconi A, Gomez H, Lopez-Guillermo A, Martinelli G, Merli F, Novero D, Orsucci L, Pavone V, Ricardi U, Storti S, Gospodarowicz MK, Cavalli F, Sarris AH, Zucca E.
    J Clin Oncol; 2011 Jul 10; 29(20):2766-72. PubMed ID: 21646602
    [Abstract] [Full Text] [Related]

  • 17. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Raje N, Pai S, Vaidya S, Gopal R, Parikh P, Saikia T, Pai V, Nadkarni K, Advani IM.
    Leuk Lymphoma; 1994 Jul 10; 14(3-4):285-90. PubMed ID: 7950917
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM, Eastern Cooperative Oncology Group Study.
    Leuk Lymphoma; 2003 Sep 10; 44(9):1515-21. PubMed ID: 14565653
    [Abstract] [Full Text] [Related]

  • 19. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
    Atra A, Gerrard M, Hobson R, Imeson JD, Ashley S, Pinkerton CR.
    Br J Cancer; 1998 Jun 10; 77(12):2281-5. PubMed ID: 9649146
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 10; 31(6):469-73. PubMed ID: 19950562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.